Cytokinetics director Robert E. Landry sells 1,000 common shares worth $74,660

PUBT · 1d ago
Cytokinetics director Robert E. Landry sells 1,000 common shares worth $74,660
  • Director Robert E. Landry sold 1,000 shares of Cytokinetics common stock on Sept. 11, 2026 at $74.66.
  • Landry held 9,184 shares directly following the transaction.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cytokinetics Incorporated published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001061983-26-000093), on September 11, 2026, and is solely responsible for the information contained therein.